In Assessing Global Health, Data Matters
For years global heath analysts have lacked a very important component when gauging the status of global diseases – accurate data. But that may soon change following a meeting of nearly 500 individuals involved in various sectors of global health. After the release of the Global Burden Disease Study, the experts gathered in Geneva to develop a consensus on principles for generating future global health estimates.
Although there was not a consensus reached on how to use the data, the move toward strengthening evidence-based global health policy making with better data is an important step.
“The fundamental challenge in this emerging era of global health will be better governance and accountability for that health spending and its efficiency, not newer medicines. The GBD study has a critical role to play in addressing that challenge,” writes the Council on Foreign Relations’ Thomas Bollyky.
Using Financial Markets To Support Cancer Research
It is not uncommon for hedge fund managers to be viewed in a negative light, but Andrew Lo may be about to change that thinking. A hedge fund manager and MIT economics professor, Lo is promoting the idea of creating a “megafund” that would finance early-stage research in cancer drugs with upwards of $30 billion.
The core of his argument is that it will involve reduced risk if a large number of investors are brought in to back as many as 150 experimental compounds at any one time. And that may be just the beginning.
Lo tells Business Insider that he believes “climate change is a good example where there’s so much opportunity for creating technology that will ultimately benefit the world.”
“As long as you can get the prop financial structure, it seems very likely that you’ll be able to earn a decent rate of return. So our hope is that we’ll start out with one proof of concept that the rest will follow pretty naturally,” he says.
US Needs To Develop Broader Vision Of Its Role On World Stage William C. Martel asserts in the first of a series of articles in The Diplomat that without a broader, larger vision the United States will continue to “drift.”
“The need for grand strategy is particularly acute in the case of the United States today. Its extraordinary power and influence make it more necessary than ever for American actions to be guided by a coherent grand strategy. The logic is inescapable: no nation can operate without a grand strategy. Without one, the nation faces a singular danger: when its policymakers are tempted to take actions without the guidance that a clear, purposeful strategic framework provides, we will see confusion, shifting policies, and ‘drift,'” he writes.
“Above all else, Americans need to answer one basic question: what principles should govern U.S. policy in an increasingly unstable world?,” he adds.